Royal Capital Wealth Management’s Anavex Life Sciences AVXL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-18,500	Closed	-$191K	–	99
2022 Q3	$191K	Hold	18,500	–	–	0.22%	83
2022 Q2	$185K	Buy	18,500 +400	+2%	+$4K	0.2%	91
2022 Q1	$223K	Buy	18,100 +1,600	+10%	+$19.7K	0.22%	92
2021 Q4	$286K	Buy	+16,500	New	+$286K	0.28%	81